Skip to content

Huaier Granule for Treatment of Plasma Cell Mastitis: a multicenter real world study

Huaier Granule for Treatment of Plasma Cell Mastitis: a multicenter real world study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004385
Enrollment
Unknown
Registered
2021-02-04
Start date
2021-02-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plasma Cell Mastitis

Interventions

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Histopathologically confirmed PCM or clinical imaging diagnosed with PCM; 2. Patients over 18 years old; 3. Before the start of the study, patient fully understands the study and is willing to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women, or plan a pregnancy during the study period; 2. With severe heart, liver, kidney, endocrine system disease patients; 3. Allergic to Huaier Granule or its composition; 4. Poor compliance or have conditions that are considered not suitable for this study investigators.

Design outcomes

Primary

MeasureTime frame
EORTC QLQ-C30;

Secondary

MeasureTime frame
Karnofsky;

Countries

China

Contacts

Public ContactQifeng Yang

Qilu Hospital of Shandong University

qifengy_sdu@163.com+86 18560085168

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026